Literature DB >> 29666679

Intrauterine Fetal Blood Transfusion: Descriptive study of the first four years' experience in Oman.

Arwa Z Al-Riyami1, Mouza Al-Salmani2, Sabria N Al-Hashami3, Sabah Al-Mahrooqi1, Ali Al-Marhoobi1, Sumaiya Al-Hinai1, Saif Al-Hosni1, Sathiya M Panchatcharam4, Zainab A Al-Arimi5.   

Abstract

OBJECTIVES: Haemolytic disease of the fetus and newborn (HDFN) causes hydrops fetalis. The successful treatment of HDFN has been reported with intrauterine blood transfusion (IUT). This study aimed to describe the initial experience with IUT procedures in Oman.
METHODS: This retrospective observational study took place at the Royal Hospital and Sultan Qaboos University Hospital Blood Bank, Muscat, Oman, and included all women who underwent IUT procedures in Oman between March 2012 and March 2016. Gestational and neonatal outcomes were assessed, including complications, morbidity, neurodevelopmental sequelae and mortality.
RESULTS: A total of 28 IUT procedures for 13 fetuses carried by 11 women were performed. Gestational age at the time of referral ranged from 13-30 weeks, while the median gestational age at first IUT procedure was 26 weeks (range: 19-30 weeks). Indications for the procedure included HDFN caused by anti-D (n = 6), a combination of anti-D and anti-C (n = 4), anti-K (n = 1) and anti-Jsb (n = 1) antibodies and nonimmune hydrops fetalis due to a congenital parvovirus infection (n = 1). Median fetal haemoglobin levels at the beginning and end of the procedure were 4.6 g/dL and 12.8 g/dL, respectively. Most procedures were transplacental intravascular transfusions through the placental umbilical cord root (71.4%), followed by transamniotic intravascular transfusions (14.3%). The overall survival rate was 61.5%, with five deaths; of these, four were intrauterine and one was an early neonatal death due to non-resolved hydrops and severe cardiac dysfunction.
CONCLUSION: As a relatively novel obstetric procedure in Oman, IUT seems to result in a favourable outcome for hydropic fetuses.

Entities:  

Keywords:  Anemia; Fetal Death; Fetus; Hydrops Fetalis; Intrauterine Blood Transfusion; Oman

Mesh:

Year:  2018        PMID: 29666679      PMCID: PMC5892811          DOI: 10.18295/squmj.2018.18.01.006

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  35 in total

1.  INTRAUTERINE TRANSFUSION OF FOETUS IN HAEMOLYTIC DISEASE.

Authors:  A W LILEY
Journal:  Br Med J       Date:  1963-11-02

2.  Amendments and corrections to the 'Transfusion Guidelines for neonates and older children' (BCSH, 2004a); and to the 'Guidelines for the use of fresh frozen plasma, cryoprecipitate and cryosupernatant' (BCSH, 2004b).

Authors: 
Journal:  Br J Haematol       Date:  2007-02       Impact factor: 6.998

Review 3.  Fetal transfusion for red blood cell alloimmunization in pregnancy.

Authors:  B Schumacher; K J Moise
Journal:  Obstet Gynecol       Date:  1996-07       Impact factor: 7.661

Review 4.  Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn - review on current management and outcome.

Authors:  Carolien Zwiers; Inge van Kamp; Dick Oepkes; Enrico Lopriore
Journal:  Expert Rev Hematol       Date:  2017-03-20       Impact factor: 2.929

5.  Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses.

Authors:  G Mari; R L Deter; R L Carpenter; F Rahman; R Zimmerman; K J Moise; K F Dorman; A Ludomirsky; R Gonzalez; R Gomez; U Oz; L Detti; J A Copel; R Bahado-Singh; S Berry; J Martinez-Poyer; S C Blackwell
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

Review 6.  Red blood cell alloimmunization in pregnancy.

Authors:  Kenneth J Moise
Journal:  Semin Hematol       Date:  2005-07       Impact factor: 3.851

Review 7.  Intrauterine blood transfusion: current indications and associated risks.

Authors:  Irene T M Lindenburg; Inge L van Kamp; Dick Oepkes
Journal:  Fetal Diagn Ther       Date:  2014-06-05       Impact factor: 2.587

8.  Procedure-related complications and perinatal outcome after intrauterine transfusions in red cell alloimmunization in Stockholm.

Authors:  Eleonor Tiblad; Marius Kublickas; Gunilla Ajne; The Hung Bui; Sverker Ek; Anita Karlsson; Agneta Wikman; Magnus Westgren
Journal:  Fetal Diagn Ther       Date:  2011-10-19       Impact factor: 2.587

Review 9.  Management of rhesus alloimmunization in pregnancy.

Authors:  Kenneth J Moise
Journal:  Obstet Gynecol       Date:  2008-07       Impact factor: 7.661

10.  Intrauterine transfusion for fetal anemia due to red blood cell alloimmunization: 14 years experience in Leuven.

Authors:  S A Pasman; L Claes; L Lewi; D Van Schoubroeck; A Debeer; M Emonds; E Geuten; L De Catte; R Devlieger
Journal:  Facts Views Vis Obgyn       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.